Published in Oncology Business Week, July 16th, 2006
Covance also announced it has acquired substantially all of the assets of Signet Laboratories, Inc. Signet, which is based in Dedham, Massachusetts, is a provider of monoclonal antibodies used in the research of cancer, infectious disease, and neurodegenerative disease.
The mouse monoclonal anti-L1 clone 14.10 released by Signet...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week